IDA has a wealth of experience in a broad range of therapeutic areas:

Indication Stategic/ KOL Regulatory/ Product Development ICC/CTN PHASE 1 PHASE 2-3 / Observ. MAH (ODD, SAKIGAKE, NDA) Partnering Support
CNS
CIDP          
Fibromyalgia        
Insomnia  
Narcolepsy            
Stroke (AIS)        
Stroke (SAH)          
Cardiovascular
ACS          
Arteriosclerosis            
Arterial Fibrillation            
Ischemia            
PAH      
Dermatology
Acne          
Aesthetic Injectable          
Atopic Dermatitis    
Hematology
Acute Bleeding        
Bleeding Control        
Hemophilia        
Infectious Disease
MRSA    
Onychomycosis        
Metabolic
Diabetes    
Diabetic Neuropathy          
Musculoskeletal
Gout            
Osteoporosis          
Rheumatoid Arthritis          
Oncology
Brain Cancer        
CCA/BTC (Orphan)        
CSCC (Orphan)          
HCC            
Mesothelioma            
NSCLC      
NHL (Orphan)        
Pancreatic Cancer            
Prostate Cancer          
Radiation Dermatitis          
SCLC          
Ophthalmology
Allergy        
AMD          
Anti-infective          
Corneal EC Protection          
Dry Eye      
Post-Op Inflammation        
Orphan Disease
AA Amyloidosis
AL Amyloidosis        
Hereditary Angioedema      
Lupus Nephritis      
Mitochondrial Disease          
Prader Willi Syndrome          
Primary Biliary Cirrhosis          
sIBM          
Other
Allergy (DNA Vaccine)        
COPD        
Enuresis & Nocturia            
General Anesthesia        
GVHD (Cell Therapy)          

Download PDF version of "IDA's experience" here.

© 2016 IDA Integrated Development Associates.